Page last updated: 2024-09-05

sb 203580 and seglitide

sb 203580 has been researched along with seglitide in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(seglitide)
Trials
(seglitide)
Recent Studies (post-2010) (seglitide)
3,48941,1377423

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)seglitide (IC50)
Somatostatin receptor type 2Homo sapiens (human)0.0016
Somatostatin receptor type 3Homo sapiens (human)0.105
Somatostatin receptor type 5Homo sapiens (human)0.081

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alrefai, WA; Bansal, N; Dudeja, PK; Gill, RK; Ramaswamy, K; Saksena, S; Theegala, S; Tyagi, S1

Other Studies

1 other study(ies) available for sb 203580 and seglitide

ArticleYear
Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 297, Issue:5

    Topics: Basigin; Butyrates; Caco-2 Cells; Cell Membrane; Epithelial Cells; Humans; Imidazoles; Intestinal Mucosa; Kinetics; Monocarboxylic Acid Transporters; p38 Mitogen-Activated Protein Kinases; Peptides, Cyclic; Protein Binding; Protein Kinase Inhibitors; Pyridines; Receptors, Somatostatin; Somatostatin; Symporters

2009